-
1
-
-
0031024171
-
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
-
DOI 10.1016/S0169-409X(96)00423-1, PII S0169409X96004231
-
Lipinski C, Lombardo F, Dominy B, Feeney P. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3-25 (Pubitemid 27046991)
-
(1997)
Advanced Drug Delivery Reviews
, vol.23
, Issue.1-3
, pp. 3-25
-
-
Lipinski, C.A.1
Lombardo, F.2
Dominy, B.W.3
Feeney, P.J.4
-
5
-
-
9744232909
-
Time-related differences in the physical property profiles of oral drugs
-
DOI 10.1021/jm049717d
-
Leeson PD, Davis AM. Time-related differences in the physical property profiles of oral drugs. J Med Chem 2004;47:6338-48 (Pubitemid 39587257)
-
(2004)
Journal of Medicinal Chemistry
, vol.47
, Issue.25
, pp. 6338-6348
-
-
Leeson, P.D.1
Davis, A.M.2
-
6
-
-
35748934487
-
The influence of drug-like concepts on decision-making in medicinal chemistry
-
DOI 10.1038/nrd2445, PII NRD2445
-
Leeson PD, Springthorpe B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 2007;6:881-90 (Pubitemid 350042396)
-
(2007)
Nature Reviews Drug Discovery
, vol.6
, Issue.11
, pp. 881-890
-
-
Leeson, P.D.1
Springthorpe, B.2
-
7
-
-
79851508525
-
Impact of ion class and time on oral drug molecular properties
-
Leeson P, St-Gallay S. Impact of ion class and time on oral drug molecular properties. Med Chem Commun 2011;2:91-105
-
(2011)
Med Chem Commun
, vol.2
, pp. 91-105
-
-
Leeson, P.1
St-Gallay, S.2
-
8
-
-
80053928594
-
What do medicinal chemists actually make? A 50-year retrospective
-
Walters WP, Green J, Weiss JR, Murcko MA. What do medicinal chemists actually make? A 50-year retrospective. J Med Chem 2011;54:6405-16
-
(2011)
J Med Chem
, vol.54
, pp. 6405-6416
-
-
Walters, W.P.1
Green, J.2
Weiss, J.R.3
Murcko, M.A.4
-
9
-
-
79957698619
-
The medicinal Chemist's toolbox: An analysis of reactions used in the pursuit of drug candidates
-
Roughley SD, Jordan AM. The medicinal Chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates. J Med Chem 2011;54:3451-79
-
(2011)
J Med Chem
, vol.54
, pp. 3451-3479
-
-
Roughley, S.D.1
Jordan, A.M.2
-
10
-
-
84856386727
-
-
World Drug Index
-
World Drug Index. Available from: http://thomsonreuters.com/products- services/science/science-products/az/world-drug-index/
-
-
-
-
11
-
-
0032600640
-
A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases
-
Ghose AK, Viswanadhan VN, Wendoloski JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1999;1:55-68
-
(1999)
J Comb Chem
, vol.1
, pp. 55-68
-
-
Ghose, A.K.1
Viswanadhan, V.N.2
Wendoloski, J.J.3
-
12
-
-
0034073605
-
Property distribution of drug-related chemical databases
-
DOI 10.1023/A:1008130001697
-
Oprea TI. Property distribution of drug-related chemical databases. J Comput Aided Mol Des 2000;14:251-64 (Pubitemid 30175944)
-
(2000)
Journal of Computer-Aided Molecular Design
, vol.14
, Issue.3
, pp. 251-264
-
-
Oprea, T.I.1
-
13
-
-
84856371529
-
-
Comrehensive Medicinal Chemistry Database
-
Comrehensive Medicinal Chemistry Database. Available from: http://accelrys. com/products/databases/bioactivity/comprehensivemedicinal- chemistry.html
-
-
-
-
14
-
-
84856371530
-
-
MACCS Drug Data Report
-
MACCS Drug Data Report. Available from: http://accelrys.com/products/ databases/bioactivity/mddr.html
-
-
-
-
15
-
-
0037208308
-
Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry
-
Feher M, Schmidt JM. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Model 2003;43:218-27
-
(2003)
J Chem Inf Model
, vol.43
, pp. 218-227
-
-
Feher, M.1
Schmidt, J.M.2
-
16
-
-
71049126548
-
Escape from flatland: Increasing saturation as an approach to improving clinical success
-
Lovering F, Bikker J, Humblet C. Escape from flatland: increasing saturation as an approach to improving clinical success. J Med Chem 2009;52:6752-6
-
(2009)
J Med Chem
, vol.52
, pp. 6752-6756
-
-
Lovering, F.1
Bikker, J.2
Humblet, C.3
-
17
-
-
70350409235
-
The impact of aromatic ring count on compound developability-are too many aromatic rings a liability in drug design?
-
Ritchie TJ, Macdonald SJF. The impact of aromatic ring count on compound developability-are too many aromatic rings a liability in drug design? Drug Discov Today 2009;14:1011-20
-
(2009)
Drug Discov Today
, vol.14
, pp. 1011-1020
-
-
Ritchie, T.J.1
Sjf, M.2
-
18
-
-
80052601462
-
Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules
-
Luker T, Alcaraz L, Chohan KK, et al. Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules. Bioorg Med Chem Lett 2011;21:5673-9
-
(2011)
Bioorg Med Chem Lett
, vol.21
, pp. 5673-5679
-
-
Luker, T.1
Alcaraz, L.2
Chohan, K.K.3
-
19
-
-
78650459806
-
Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles
-
Clemons PA, Bodycombe NE, Carrinski HA, et al. Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles. Proc Natl Acad Sci USA 2010;107:18787-92
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 18787-18792
-
-
Clemons, P.A.1
Bodycombe, N.E.2
Carrinski, H.A.3
-
20
-
-
77955816970
-
Distinct biological network properties between the targets of natural products and disease genes
-
Dancik V, Seiler KP, Young DW, et al. Distinct biological network properties between the targets of natural products and disease genes. J Am Chem Soc 2010;132:9259-61
-
(2010)
J Am Chem Soc
, vol.132
, pp. 9259-9261
-
-
Dancik, V.1
Seiler, K.P.2
Young, D.W.3
-
21
-
-
0032572816
-
A scoring scheme for discriminating between drugs and nondrugs
-
DOI 10.1021/jm9706776
-
Sadowski J, Kubinyi H. A scoring scheme for discriminating between drugs and nondrugs. J Med Chem 1998;41:3325-9 (Pubitemid 28406539)
-
(1998)
Journal of Medicinal Chemistry
, vol.41
, Issue.18
, pp. 3325-3329
-
-
Sadowski, J.1
Kubinyi, H.2
-
22
-
-
0032572819
-
Can we learn to distinguish between 'drug-like' and 'nondrug-like' molecules?
-
DOI 10.1021/jm970666c
-
Ajay, Walters WP, Murcko MA. Can we learn to distinguish between "Drug-like" and 'Nondrug-like' molecules? J Med Chem 1998;41:3314-24 (Pubitemid 28406538)
-
(1998)
Journal of Medicinal Chemistry
, vol.41
, Issue.18
, pp. 3314-3324
-
-
Ajay1
Walters, W.P.2
Murcko, M.A.3
-
24
-
-
0036682234
-
Descriptors, physical properties, and drug-likeness
-
DOI 10.1021/jm011027b
-
Brustle M, Beck B, Schindler T, et al. Descriptors, physical properties, and drug-likeness. J Med Chem 2002;45:3345-55 (Pubitemid 34824024)
-
(2002)
Journal of Medicinal Chemistry
, vol.45
, Issue.16
, pp. 3345-3355
-
-
Brustle, M.1
Beck, B.2
Schindler, T.3
King, W.4
Mitchell, T.5
Clark, T.6
-
25
-
-
35248856018
-
A large descriptor set and a probabilistic kernel-based classifier significantly improve druglikeness classification
-
DOI 10.1021/ci700107y
-
Li Q, Bender A, Pei J, Lai L. A large descriptor set and a probabilistic kernel-based classifier significantly improve druglikeness classification. J Chem Inf Model 2007;47:1776-86 (Pubitemid 47561125)
-
(2007)
Journal of Chemical Information and Modeling
, vol.47
, Issue.5
, pp. 1776-1786
-
-
Li, Q.1
Bender, A.2
Pei, J.3
Lai, L.4
-
26
-
-
77949822709
-
Predicting oral druglikeness by iterative stochastic elimination
-
Rayan A, Marcus D, Goldblum A. Predicting oral druglikeness by iterative stochastic elimination. J Chem Inf Model 2010;50:437-45
-
(2010)
J Chem Inf Model
, vol.50
, pp. 437-445
-
-
Rayan, A.1
Marcus, D.2
Goldblum, A.3
-
27
-
-
0141994392
-
Drugs and nondrugs: An effective discrimination with topological methods and artificial neural networks
-
Murcia-Soler M, Perez-Gimenez F, Garcia-March FJ, et al. Drugs and nondrugs: an effective discrimination with topological methods and artificial neural networks. J Chem Inf Model 2003;43:1688-702
-
(2003)
J Chem Inf Model
, vol.43
, pp. 1688-1702
-
-
Murcia-Soler, M.1
Perez-Gimenez, F.2
Garcia-March, F.J.3
-
28
-
-
0035913046
-
Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS)
-
DOI 10.1021/jm0010670
-
Anzali S, Barnickel G, Cezanne B, et al. Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS). J Med Chem 2001;44:2432-7 (Pubitemid 32861447)
-
(2001)
Journal of Medicinal Chemistry
, vol.44
, Issue.15
, pp. 2432-2437
-
-
Anzali, S.1
Barnickel, G.2
Cezanne, B.3
Krug, M.4
Filimonov, D.5
Poroikov, V.6
-
29
-
-
33846886129
-
Separating drugs from nondrugs: A statistical approach using atom pair distributions
-
DOI 10.1021/ci600329u
-
Hutter MC. Separating drugs from nondrugs: a statistical approach using atom pair distributions. J Chem Inf Model 2007;47:186-94 (Pubitemid 46225575)
-
(2007)
Journal of Chemical Information and Modeling
, vol.47
, Issue.1
, pp. 186-194
-
-
Hutter, M.C.1
-
30
-
-
42149109229
-
Gradual in silico filtering for druglike substances
-
DOI 10.1021/ci700351y
-
Schneider N, Jackels C, Andres C, Hutter MC. Gradual in silico filtering for druglike substances. J Chem Inf Model 2008;48:613-28 (Pubitemid 351535429)
-
(2008)
Journal of Chemical Information and Modeling
, vol.48
, Issue.3
, pp. 613-628
-
-
Schneider, N.1
Jackels, C.2
Andres, C.3
Hutter, M.C.4
-
32
-
-
0037124196
-
Drugs, leads, and drug-likeness: An analysis of some recently launched drugs
-
DOI 10.1016/S0960-894X(02)00244-5, PII S0960894X02002445
-
Proudfoot JR. Drugs, leads, and druglikeness: an analysis of some recently launched drugs. Bioorg Med Chem Lett 2002;12:1647-50 (Pubitemid 34569263)
-
(2002)
Bioorganic and Medicinal Chemistry Letters
, vol.12
, Issue.12
, pp. 1647-1650
-
-
Proudfoot, J.R.1
-
33
-
-
0033576601
-
The design of leadlike combinatorial libraries
-
DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0. CO;2-U
-
Teague S, Davis A, Leeson P, Oprea T. The design of leadlike combinatorial libraries. Angew Chem Int Ed Engl 1999;38:3743-8 (Pubitemid 30022004)
-
(1999)
Angewandte Chemie - International Edition
, vol.38
, Issue.24
, pp. 3743-3748
-
-
Teague, S.J.1
Davis, A.M.2
Leeson, P.D.3
Oprea, T.4
-
34
-
-
0035324944
-
Molecular complexity and its impact on the probability of finding leads for drug discovery
-
Hann M, Leach A, Harper G. Molecular complexity and its impact on the probability of finding leads for drug discovery. J Chem Inf Comput Sci 2001;41:856-64
-
(2001)
J Chem Inf Comput Sci
, vol.41
, pp. 856-864
-
-
Hann, M.1
Leach, A.2
Harper, G.3
-
35
-
-
0035438391
-
Is there a difference between leads and drugs? A historical perspective
-
Oprea TI, Davis AM, Teague SJ, Leeson PD. Is there a difference between leads and drugs? A historical perspective. J Chem Inf Model 2001;41:1308-15
-
(2001)
J Chem Inf Model
, vol.41
, pp. 1308-1315
-
-
Oprea, T.I.1
Davis, A.M.2
Teague, S.J.3
Leeson, P.D.4
-
36
-
-
77950560159
-
An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs
-
Perola E. An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs. J Med Chem 2010;53:2986-97
-
(2010)
J Med Chem
, vol.53
, pp. 2986-2997
-
-
Perola, E.1
-
37
-
-
2942564021
-
Pursuing the leadlikeness concept in pharmaceutical research
-
DOI 10.1016/j.cbpa.2004.04.003, PII S1367593104000493
-
Hann MM, Oprea TI. Pursuing the leadlikeness concept in pharmaceutical research. Curr Opin Chem Biol 2004;8:255-63 (Pubitemid 38759400)
-
(2004)
Current Opinion in Chemical Biology
, vol.8
, Issue.3
, pp. 255-263
-
-
Hann, M.M.1
Oprea, T.I.2
-
38
-
-
33847381100
-
A decade of fragment-based drug design: Strategic advances and lessons learned
-
DOI 10.1038/nrd2220, PII NRD2220
-
Hajduk PJ, Greer J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov 2007;6:211-19 (Pubitemid 46344625)
-
(2007)
Nature Reviews Drug Discovery
, vol.6
, Issue.3
, pp. 211-219
-
-
Hajduk, P.J.1
Greer, J.2
-
39
-
-
0141726877
-
A 'Rule of Three' for fragment-based lead discovery?
-
DOI 10.1016/S1359-6446(03)02831-9, PII S1359644603028319
-
Congreve M, Carr R, Murray C, Jhoti H. A "rule of three" for fragment-based lead discovery? Drug Discov Today 2003;8:876-7 (Pubitemid 37194496)
-
(2003)
Drug Discovery Today
, vol.8
, Issue.19
, pp. 876-877
-
-
Congreve, M.1
Carr, R.2
Murray, C.3
Jhoti, H.4
-
40
-
-
33845364148
-
Fragment-based drug design: How big is too big?
-
DOI 10.1021/jm060511h
-
Hajduk PJ. Fragment-based drug design: how big is too big? J Med Chem 2006;49:6972-6 (Pubitemid 44885985)
-
(2006)
Journal of Medicinal Chemistry
, vol.49
, Issue.24
, pp. 6972-6976
-
-
Hajduk, P.J.1
-
41
-
-
46849089254
-
Recent developments in fragment-based drug discovery
-
DOI 10.1021/jm8000373
-
Congreve M, Chessari G, Tisi D, Woodhead AJ. Recent developments in fragment-based drug discovery. J Med Chem 2008;51:3661-80 (Pubitemid 351956496)
-
(2008)
Journal of Medicinal Chemistry
, vol.51
, Issue.13
, pp. 3661-3680
-
-
Congreve, M.1
Chessari, G.2
Tisi, D.3
Woodhead, A.J.4
-
42
-
-
79960997906
-
Molecular complexity and fragment-based drug discovery: Ten years on
-
Leach AR, Hann MM. Molecular complexity and fragment-based drug discovery: ten years on. Curr Opin Chem Biol 2011;15:489-96
-
(2011)
Curr Opin Chem Biol
, vol.15
, pp. 489-496
-
-
Leach, A.R.1
Hann, M.M.2
-
43
-
-
39749181550
-
Generation of a set of simple, interpretable ADMET rules of thumb
-
DOI 10.1021/jm701122q
-
Gleeson MP. Generation of a set of simple, interpretable ADMET rules of thumb. J Med Chem 2008;51:817-34 (Pubitemid 351304691)
-
(2008)
Journal of Medicinal Chemistry
, vol.51
, Issue.4
, pp. 817-834
-
-
Gleeson, M.P.1
-
44
-
-
65449179589
-
Defining optimum lipophilicity and molecular weight ranges for drug candidates-molecular weight dependent lower logD limits based on permeability
-
Waring MJ. Defining optimum lipophilicity and molecular weight ranges for drug candidates-molecular weight dependent lower logD limits based on permeability. Bioorg Med Chem Lett 2009;19:2844-51
-
(2009)
Bioorg Med Chem Lett
, vol.19
, pp. 2844-2851
-
-
Waring, M.J.1
-
45
-
-
0034687231
-
Prediction of drug absorption using multivariate statistics
-
Egan WJ, Merz KM Jr, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem 2000;43:3867-77
-
(2000)
J Med Chem
, vol.43
, pp. 3867-3877
-
-
Egan, W.J.1
Merz Jr., K.M.2
Baldwin, J.J.3
-
46
-
-
69949109727
-
Using the golden triangle to optimize clearance and oral absorption
-
Johnson TW, Dress KR, Edwards M. Using the golden triangle to optimize clearance and oral absorption. Bioorg Med Chem Lett 2009;19:5560-4
-
(2009)
Bioorg Med Chem Lett
, vol.19
, pp. 5560-5564
-
-
Johnson, T.W.1
Dress, K.R.2
Edwards, M.3
-
47
-
-
18244370266
-
A bioavailability score
-
DOI 10.1021/jm0492002
-
Martin YC. A bioavailability score. J Med Chem 2005;48:3164-70 (Pubitemid 40628036)
-
(2005)
Journal of Medicinal Chemistry
, vol.48
, Issue.9
, pp. 3164-3170
-
-
Martin, Y.C.1
-
48
-
-
0037030653
-
Molecular properties that influence the oral bioavailability of drug candidates
-
DOI 10.1021/jm020017n
-
Veber D, Johnson S, Cheng H, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45:2615-23 (Pubitemid 34595232)
-
(2002)
Journal of Medicinal Chemistry
, vol.45
, Issue.12
, pp. 2615-2623
-
-
Veber, D.F.1
Johnson, S.R.2
Cheng, H.-Y.3
Smith, B.R.4
Ward, K.W.5
Kopple, K.D.6
-
49
-
-
8644219619
-
Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat
-
DOI 10.1021/jm0306529
-
Lu JJ, Crimin K, Goodwin JT, et al. Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat. J Med Chem 2004;47:6104-7 (Pubitemid 39507351)
-
(2004)
Journal of Medicinal Chemistry
, vol.47
, Issue.24
, pp. 6104-6107
-
-
Lu, J.J.1
Crimin, K.2
Goodwin, J.T.3
Crivori, P.4
Orrenius, C.5
Xing, L.6
Tandler, P.J.7
Vidmar, T.J.8
Amore, B.M.9
Wilson, A.G.E.10
Stouten, P.F.W.11
Burton, P.S.12
-
50
-
-
34247245174
-
ADME evaluation in drug discovery. 6. Can oral biavailability in humans be effectively predicted by simple molecular property-based rules?
-
DOI 10.1021/ci6003515
-
Hou T, Wang J, Zhang W, Xu X. ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules? J Chem Info Model 2007;47:460-3 (Pubitemid 46615948)
-
(2007)
Journal of Chemical Information and Modeling
, vol.47
, Issue.2
, pp. 460-463
-
-
Hou, T.1
Wang, J.2
Zhang, W.3
Xu, X.4
-
51
-
-
49849094738
-
Physiochemical drug properties associated with in vivo toxicological outcomes
-
Hughes JD, Blagg J, Price DA, et al. Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg Med Chem Lett 2008;18:4872-5
-
(2008)
Bioorg Med Chem Lett
, vol.18
, pp. 4872-485
-
-
Hughes, J.D.1
Blagg, J.2
Price, D.A.3
-
52
-
-
68149160053
-
Physicochemical drug properties associated with in vivo toxicological outcomes: A review
-
Price DA, Blagg J, Jones L, et al. Physicochemical drug properties associated with in vivo toxicological outcomes: a review. Expert Opin Drug Metab Toxicol 2009;5:921-31
-
(2009)
Expert Opin Drug Metab Toxicol
, vol.5
, pp. 921-931
-
-
Price, D.A.1
Blagg, J.2
Jones, L.3
-
53
-
-
77949375780
-
Biopharmaceutical drug targeting to the brain
-
Pardridge WM. Biopharmaceutical drug targeting to the brain. J Drug Target 2010;18:157-67
-
(2010)
J Drug Target
, vol.18
, pp. 157-167
-
-
Pardridge, W.M.1
-
54
-
-
21144467893
-
Hydrogen-bonding capacity and brain penetration
-
van de Waterbeemd H, Kansy M. Hydrogen-bonding capacity and brain penetration. Chimia (Aarau) 1992;48:299-303
-
(1992)
Chimia (Aarau)
, vol.48
, pp. 299-303
-
-
Van De Waterbeemd, H.1
Kansy, M.2
-
55
-
-
0032795192
-
Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption
-
DOI 10.1021/js9804011
-
Clark DE. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. J Pharm Sci 1999;88:807-14 (Pubitemid 29398550)
-
(1999)
Journal of Pharmaceutical Sciences
, vol.88
, Issue.8
, pp. 807-814
-
-
Clark, D.E.1
-
56
-
-
33845937770
-
Structure-brain exposure relationships
-
DOI 10.1021/jm060642i
-
Hitchcock S, Pennington L, Lin L, Lanza T Jr. Structure-brain exposure relationships. J Med Chem 2007;49:7559-83 (Pubitemid 46033646)
-
(2006)
Journal of Medicinal Chemistry
, vol.49
, Issue.26
, pp. 7559-7583
-
-
Hitchcock, S.A.1
Pennington, L.D.2
-
57
-
-
70350397386
-
Brain drug targeting: A computational approach for overcoming blood-brain barrier
-
Mehdipour AR, Hamidi M. Brain drug targeting: a computational approach for overcoming blood-brain barrier. Drug Discov Today 2009;14:1030-6
-
(2009)
Drug Discov Today
, vol.14
, pp. 1030-1036
-
-
Mehdipour, A.R.1
Hamidi, M.2
-
58
-
-
84856376107
-
-
Virtual ADMET Assessment in Target Selection and Maturation
-
Abraham M. In Silico Models to Predict Brain Uptake. Virtual ADMET Assessment in Target Selection and Maturation. 2005
-
(2005)
Silico Models to Predict Brain Uptake
-
-
Abraham, M.1
-
59
-
-
0345117308
-
ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors
-
Hou TJ, Xu XJ. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors. J Chem Info comput sci 2003;43:2137-52
-
(2003)
J Chem Info Comput Sci
, vol.43
, pp. 2137-2152
-
-
Hou, T.J.1
Xu, X.J.2
-
60
-
-
67650070045
-
Multi-parameter phenotypic profiling: Using cellular effects to characterize small-molecule compounds
-
Feng Y, Mitchison TJ, Bender A, et al. Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds. Nat Rev Drug Discov 2009;8:567-78
-
(2009)
Nat Rev Drug Discov
, vol.8
, pp. 567-578
-
-
Feng, Y.1
Mitchison, T.J.2
Bender, A.3
-
61
-
-
58149128997
-
Metabolite-likeness as a criterion in the design and selection of pharmaceutical drug libraries
-
Dobson PD, Patel Y, Kell DB. "Metabolite-likeness" as a criterion in the design and selection of pharmaceutical drug libraries. Drug Discov Today 2009;14:31-40
-
(2009)
Drug Discov Today
, vol.14
, pp. 31-40
-
-
Dobson, P.D.1
Patel, Y.2
Kell, D.B.3
-
62
-
-
33745333814
-
Can 'bacterial-metabolite-likeness' model improve odds of 'in silico' antibiotic discovery?
-
DOI 10.1021/ci050480j
-
Cherkasov A. Can 'Bacterial-Metabolite-Likeness' model improve odds of 'in Silico' antibiotic discovery? J Chem Inf Model 2006;46:1214-22 (Pubitemid 43999165)
-
(2006)
Journal of Chemical Information and Modeling
, vol.46
, Issue.3
, pp. 1214-1222
-
-
Cherkasov, A.1
-
63
-
-
34247345395
-
Comparing the chemical spaces of metabolites and available chemicals: Models of metabolite-likeness
-
DOI 10.1007/s11030-006-9054-0
-
Gupta S, Aires-de-Sousa J. Comparing the chemical spaces of metabolites and available chemicals: models of metabolite-likeness. Mol Divers 2007;11:23-36 (Pubitemid 46639419)
-
(2007)
Molecular Diversity
, vol.11
, Issue.1
, pp. 23-36
-
-
Gupta, S.1
Aires-de-Sousa, J.2
-
64
-
-
0030756360
-
Reactive compounds and in vitro false positives in HTS
-
DOI 10.1016/S1359-6446(97)01083-0, PII S1359644697010830
-
Rishton G. Reactive compounds and in vitro false positives in HTS. Drug Discov Today 1997;9:382-4 (Pubitemid 27368216)
-
(1997)
Drug Discovery Today
, vol.2
, Issue.9
, pp. 382-384
-
-
Rishton, G.M.1
-
66
-
-
77950571108
-
New substructure filters for removal of Pan Assay Interference Compounds (PAINS) from screening libraries and for their exclusion in bioassays
-
Baell JB, Holloway GA. New substructure filters for removal of Pan Assay Interference Compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 2010;53:2719-40
-
(2010)
J Med Chem
, vol.53
, pp. 2719-2740
-
-
Baell, J.B.1
Holloway, G.A.2
-
67
-
-
77955349319
-
Genotoxic impurities: From structural alerts to qualification
-
Snodin DJ. Genotoxic impurities: from structural alerts to qualification. Org Process Res Dev 2010;14:960-76
-
(2010)
Org Process Res Dev
, vol.14
, pp. 960-976
-
-
Snodin, D.J.1
-
68
-
-
79960701365
-
Identification of toxifying and detoxifying moieties for mutagenicity prediction by priority assessment
-
Casalegno M, Benfenati E, Sello G. Identification of toxifying and detoxifying moieties for mutagenicity prediction by priority assessment. J Chem Inf Model 2011;51:1564-74
-
(2011)
J Chem Inf Model
, vol.51
, pp. 1564-1574
-
-
Casalegno, M.1
Benfenati, E.2
Sello, G.3
-
69
-
-
79960205454
-
Assessment of methods to define the applicability domain of structural alert models
-
Ellison CM, Sherhod R, Cronin MTD, et al. Assessment of methods to define the applicability domain of structural alert models. J Chem Inf Model 2011;51:975-85
-
(2011)
J Chem Inf Model
, vol.51
, pp. 975-985
-
-
Ellison, C.M.1
Sherhod, R.2
Mtd, C.3
-
70
-
-
80053004364
-
Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: A perspective based on the critical examination of trends in the top 200 drugs marketed in the United States
-
Stepan AF, Walker DP, Bauman J, et al. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem Res Toxicol 2011;24:1345-410
-
(2011)
Chem Res Toxicol
, vol.24
, pp. 1345-1410
-
-
Stepan, A.F.1
Walker, D.P.2
Bauman, J.3
-
71
-
-
79961119877
-
In silico toxicology models and databases as FDA critical path initiative toolkits
-
Valerio LG. In silico toxicology models and databases as FDA critical path initiative toolkits. Hum Genomics 2011;5:200-7
-
(2011)
Hum Genomics
, vol.5
, pp. 200-207
-
-
Valerio, L.G.1
-
72
-
-
13244266921
-
Lead- and drug-like compounds: The rule-of-five revolution
-
DOI 10.1016/j.ddtec.2004.11.007, PII S1740674904000551
-
Lipinski C. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 2004;1:337-41 (Pubitemid 40186335)
-
(2004)
Drug Discovery Today: Technologies
, vol.1
, Issue.4
, pp. 337-341
-
-
Lipinski, C.A.1
-
73
-
-
80052831391
-
Drug discovery in the next decade: Innovation needed ASAP
-
Bennani YL. Drug discovery in the next decade: innovation needed ASAP. Drug Discov Today 2011;16:779-92
-
(2011)
Drug Discov Today
, vol.16
, pp. 779-792
-
-
Bennani, Y.L.1
-
74
-
-
79851514658
-
Lead optimization in the nondrug-like space
-
Zhao H. Lead optimization in the nondrug-like space. Drug Discov Today 2011;16:158-63
-
(2011)
Drug Discov Today
, vol.16
, pp. 158-163
-
-
Zhao, H.1
-
75
-
-
78650746852
-
Methods for the synthesis of macrocycle libraries for drug discovery
-
Terrett NK. Methods for the synthesis of macrocycle libraries for drug discovery. Drug Discov Today Technol 2010;7:e97-e104
-
(2010)
Drug Discov Today Technol
, vol.7
-
-
Terrett, N.K.1
-
76
-
-
77956294635
-
Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic
-
Bird GH, Madani N, Perry AF, et al. Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic. Proc Natl Acad Sci USA 2010;107:14093-8
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 14093-14098
-
-
Bird, G.H.1
Madani, N.2
Perry, A.F.3
-
77
-
-
77952542911
-
Current strategies for diversity-oriented synthesis
-
Dandapani S, Marcaurelle LA. Current strategies for diversity-oriented synthesis. Curr Opin Chem Biol 2010;14:362-70
-
(2010)
Curr Opin Chem Biol
, vol.14
, pp. 362-370
-
-
Dandapani, S.1
Marcaurelle, L.A.2
-
79
-
-
84856371528
-
In-silico assay for assessing phospholipidosis potential of small drug like molecules: Training, validation and refinement using several datasets
-
In press
-
Fischer H, Atzpodien EA, Csato M, et al. In-silico assay for assessing phospholipidosis potential of small drug like molecules: training, validation and refinement using several datasets. J Med Chem 2011; In press
-
(2011)
J Med Chem
-
-
Fischer, H.1
Atzpodien, E.A.2
Csato, M.3
|